Moreover, the data published on the Cancer Genome Atlas database (TCGA; www.cancergenome.nih.gov (accessed on 1 November 2022); www.cbioportal.org (accessed on 1 November 2022)) show that the RHOA gene is rarely amplified and is often deleted in different cancer types, and that RHOA mutations are associated with a worse overall survival of non-Hodgkin lymphoma (NHL) patients. Here, RHOA is linked to non-Hodgkin lymphoma.